Methylation at SLC6A4 also has been related to cardiometabolic health, as one study found promoter hypermethylation in blood leukocytes to be significantly associated with an increased prevalence of obesity (16). Here, SLC6A4 is linked to obesity due to melanocortin 4 receptor deficiency.